⌘K
Loading ticker…
As of 2026-08-21, NovoCure Limited Ordinary Shares (NVCR) has a 3-month relative strength percentile of 38 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 58. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.0%, relative volume 0.91×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
NVCR is in a stage 2 uptrend, week 3. Currently in a 21-day base; basing ADR 6.0% (broad 5.6%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 3.8% / 21.8%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
NVCR is held by 13 ETFs as of May 2026. Top owner: VTWO at 0.05% weight, $9M notional. Top 3 carry $16M.
Held by 31 ETFs · $127M across latest filings · largest weight 2.04% (HTEC).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.05% | $9M | — |
| VHTVanguard Health Care ETF | 0.03% | $5M | — |
| ESML | 0.07% | $2M | +0.02 pp |
| VTWG | 0.10% | $2M | — |
| AGNG | 0.48% | $392K | +0.28 pp |
| ESGV | 0.00% | $386K | — |
| HEAL | 1.32% | $330K | −0.41 pp |
| VTHRVanguard Russell 3000 ETF | 0.00% | $135K | — |
| WSML | 0.02% | $104K | new |
| IBBQ | 0.15% | $103K | +0.04 pp |
Showing 10 of 13 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NVCR Jan avg: -1.07% median: -5.43% win: 25% σ: 17.91% n: 4 2022-04-12 → 2026-07-31 | NVCR Feb avg: -4.40% median: -2.80% win: 50% σ: 16.97% n: 4 2022-04-12 → 2026-07-31 | NVCR Mar avg: -11.65% median: -13.41% win: 25% σ: 11.45% n: 4 2022-04-12 → 2026-07-31 | NVCR Apr avg: 4.47% median: 1.80% win: 60% σ: 22.78% n: 5 2022-04-12 → 2026-07-31 | NVCR May avg: 22.23% median: 8.97% win: 100% σ: 32.32% n: 5 2022-04-12 → 2026-07-31 | NVCR Jun avg: -19.17% median: -13.54% win: 0% σ: 14.04% n: 5 2022-04-12 → 2026-07-31 | NVCR Jul avg: -5.53% median: -2.17% win: 20% σ: 25.60% n: 5 2022-04-12 → 2026-07-31 | NVCR Aug avg: -4.92% median: -4.03% win: 50% σ: 23.41% n: 4 2022-04-12 → 2026-07-31 (current) | NVCR Sep avg: -12.27% median: -13.54% win: 25% σ: 13.88% n: 4 2022-04-12 → 2026-07-31 | NVCR Oct avg: -7.09% median: -4.94% win: 0% σ: 7.49% n: 4 2022-04-12 → 2026-07-31 | NVCR Nov avg: 8.25% median: 4.37% win: 50% σ: 17.21% n: 4 2022-04-12 → 2026-07-31 | NVCR Dec avg: 16.69% median: 11.31% win: 75% σ: 24.14% n: 4 2022-04-12 → 2026-07-31 |